Trastuzumab emtansine (T-DM1) in patients With HER2-positive metastatic breast cancer previously treated with chemotherapy and 2 or more HER2-targeted agents: Results from the T-PAS expanded access study

Denise A. Yardley, Ian E. Krop, Patricia M. LoRusso, Musa Mayer, Brian Barnett, Bongin Yoo, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Trastuzumab emtansine (T-DM1) in patients With HER2-positive metastatic breast cancer previously treated with chemotherapy and 2 or more HER2-targeted agents: Results from the T-PAS expanded access study'. Together they form a unique fingerprint.

Medicine & Life Sciences